Trial Profile
A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose Escalation, Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 20 Nov 2014
Price :
$35
*
At a glance
- Drugs KD 018 (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer; Diarrhoea
- Focus Adverse reactions
- Sponsors PhytoCeutica
- 20 Nov 2014 New trial record